358 related articles for article (PubMed ID: 19907168)
1. D-dimers predict stroke subtype when assessed early.
Isenegger J; Meier N; Lämmle B; Alberio L; Fischer U; Nedeltchev K; Gralla J; Kohler HP; Mattle HP; Arnold M
Cerebrovasc Dis; 2010; 29(1):82-6. PubMed ID: 19907168
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of markers of thrombin generation in the acute and chronic phases of non cardioembolic ischemic stroke.
Soncini M; Gasparini P; Lorena M; Motta A; Cimminiello C
Minerva Cardioangiol; 2000 Nov; 48(11):349-56. PubMed ID: 11214426
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke.
Hajsadeghi S; Kashani Amin L; Bakhshandeh H; Rohani M; Azizian AR; Jafarian Kerman SR
J Stroke Cerebrovasc Dis; 2013 May; 22(4):554-60. PubMed ID: 23422348
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke.
Bernard TJ; Fenton LZ; Apkon SD; Boada R; Wilkening GN; Wilkinson CC; Soep JB; Miyamoto SD; Tripputi M; Armstrong-Wells J; Benke TA; Manco-Johnson MJ; Goldenberg NA
J Pediatr; 2010 Apr; 156(4):651-6. PubMed ID: 20022340
[TBL] [Abstract][Full Text] [Related]
5. Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke.
Haapaniemi E; Soinne L; Syrjälä M; Kaste M; Tatlisumak T
Acta Neurol Scand; 2004 Oct; 110(4):242-7. PubMed ID: 15355488
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of intracardiac thrombi by various imaging techniques and activation of platelets and coagulation-fibrinolysis in patients with cardioembolic stroke].
Uchiyama S; Yamazaki M; Iwata M; Maruyama S
Rinsho Shinkeigaku; 1996 Mar; 36(3):429-35. PubMed ID: 8741345
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical diagnosis of small-vessel disease in acute ischemic stroke.
Brouns R; Van Den Bossche J; De Surgeloose D; Sheorajpanday R; De Deyn PP
J Neurol Sci; 2009 Oct; 285(1-2):185-90. PubMed ID: 19619884
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.
Rallidis LS; Vikelis M; Panagiotakos DB; Liakos GK; Krania E; Kremastinos DT
Acta Neurol Scand; 2008 Jun; 117(6):415-20. PubMed ID: 18093263
[TBL] [Abstract][Full Text] [Related]
9. Alterations of haemostatic markers in various subtypes and phases of stroke.
Yamazaki M; Uchiyama S; Maruyama S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
[TBL] [Abstract][Full Text] [Related]
10. D-dimer is not a long-term prognostic marker following acute cerebral ischemia.
Squizzato A; Ageno W; Finazzi S; Mera V; Romualdi E; Bossi A; Venco A
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):303-6. PubMed ID: 16651873
[TBL] [Abstract][Full Text] [Related]
11. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer.
Kono T; Ohtsuki T; Hosomi N; Takeda I; Aoki S; Sueda Y; Ishihara K; Nakamura T; Yamawaki T; Matsumoto M
Geriatr Gerontol Int; 2012 Jul; 12(3):468-74. PubMed ID: 22233138
[TBL] [Abstract][Full Text] [Related]
13. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Vassiliadis T; Mpoumponaris A; Giouleme O; Evgenidis N
Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
[TBL] [Abstract][Full Text] [Related]
14. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
15. Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction.
Tombul T; Atbas C; Anlar O
J Clin Neurosci; 2005 May; 12(4):429-34. PubMed ID: 15925775
[TBL] [Abstract][Full Text] [Related]
16. Fibrin D-dimer in thrombogenic disorders.
Matsuo T; Kobayashi H; Kario K; Suzuki S
Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
[TBL] [Abstract][Full Text] [Related]
17. Thrombin activity throughout the acute phase of acute ST-elevation myocardial infarction and the relation to outcome.
Ulrich-Möckel NV; Riehle M; Vollert J; Heller G; Störk T; Riess H; Müller C; Frei U; Möckel M
Biomarkers; 2009 Aug; 14(5):311-6. PubMed ID: 19552570
[TBL] [Abstract][Full Text] [Related]
18. Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems.
Chilver-Stainer L; Lämmle B; Alberio L
Thromb Haemost; 2004 Feb; 91(2):276-82. PubMed ID: 14961154
[TBL] [Abstract][Full Text] [Related]
19. Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification.
Pinto A; Tuttolomondo A; Di Raimondo D; Fernandez P; Licata G
Int Angiol; 2006 Sep; 25(3):261-7. PubMed ID: 16878074
[TBL] [Abstract][Full Text] [Related]
20. Association of pulse pressure with fibrinolysis in patients with type 2 diabetes.
Wakabayashi I; Masuda H
Thromb Res; 2007; 121(1):95-102. PubMed ID: 17439823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]